DOI QR코드

DOI QR Code

Associations of Serum Ferritin and Transferrin % Saturation With All-cause, Cancer, and Cardiovascular Disease Mortality: Third National Health and Nutrition Examination Survey Follow-up Study

  • Kim, Ki-Su (Department of Preventative Medicine, Kyungpook National University School of Medicine) ;
  • Son, Hye-Gyeong (Department of Preventative Medicine, Kyungpook National University School of Medicine) ;
  • Hong, Nam-Soo (Department of Preventative Medicine, Kyungpook National University School of Medicine) ;
  • Lee, Duk-Hee (Department of Preventative Medicine, Kyungpook National University School of Medicine)
  • Received : 2011.11.11
  • Accepted : 2012.01.25
  • Published : 2012.05.31

Abstract

Objectives: Even though experimental studies have suggested that iron can be involved in generating oxidative stress, epidemiologic studies on the association of markers of body iron stores with cardiovascular disease or cancer remain controversial. This study was performed to examine the association of serum ferritin and transferrin saturation (%TS) with all-cause, cancer, and cardiovascular mortality. Methods: The study subjects were men aged 50 years or older and postmenopausal women of the Third National Health and Nutrition Examination Survey 1988-1994. Participants were followed-up for mortality through December 31, 2006. Results: Serum ferritin was not associated with all-cause, cancer, or cardiovascular mortality for either men or postmenopausal women. However, all-cause, cancer, and cardiovascular mortality were inversely associated with %TS in men. Compared with men in the lowest quintile, adjusted hazard ratios for all-cause, cancer, and cardiovascular mortality were 0.85, 0.86, 0.76, and 0.74 ($p$ for trend < 0.01), 0.82, 0.73, 0.75, and 0.63 ($p$ for trend < 0.01), and 0.86, 0.81, 0.72, and 0.76 ($p$ for trend < 0.01), respectively. For postmenopausal women, inverse associations were also observed for all-cause and cardiovascular mortality, but cancer mortality showed the significantly lower mortality only in the 2nd quintile of %TS compared with that of the 1st quintile. Conclusions: Unlike speculation on the role of iron from experimental studies, %TS was inversely associated with allcause, cancer and cardiovascular mortality in men and postmenopausal women. On the other hand, serum ferritin was not associated with all-cause, cancer, or cardiovascular mortality.

Keywords

References

  1. Crichton RR. Inorganic biochemistry of iron metabolism. New York: E. Horwood; 1991.
  2. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85.
  3. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996;25(1):57-74.
  4. Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 2000;10(7):441-448.
  5. Mainous AG 3rd, Gill JM, Carek PJ. Elevated serum transferrin saturation and mortality. Ann Fam Med 2004;2(2):133-138.
  6. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330(16):1119-1124.
  7. Menke A, Muntner P, Fernandez-Real JM, Guallar E. The association of biomarkers of iron status with mortality in US adults. Nutr Metab Cardiovasc Dis 2011; in press.
  8. Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. Total mortality by transferrin saturation levels: two general population studies and a metaanalysis. Clin Chem 2011;57(3):459-466.
  9. Jia X, Aucott LS, McNeill G. Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr 2007;98(3):593-599.
  10. Lee DH, Zacharski LR, Jacobs DR Jr. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes. Am Heart J 2006;151(6):1247.e1-1247.e7.
  11. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1 1994;(32):1-407.
  12. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: NCHS research ethics review board (ERB) approval [cited 2011 Sep 28]. Available from: http://www.cdc.gov/nchs/nhanes/ irba98.htm.
  13. National Center for Health Statistics. The third National Health and Nutrition Examination Survey (NHANES III) linked mortality file: mortality follow-up through 2006; 2009 [cited 2011 Sep 28]. Available from: http:// www.cdc.gov/nchs/data/datalinkage/matching_methodolo gy_nhanes3_final.pdf.
  14. National Center for Health Statistics (NCHS). Third National Health and Nutrition Examination Survey (NHANES III) linked mortality file: public-use file layout and detailed notes for selected variables [cited 2011 sep 28]. Available from: http://www.cdc.gov/nchs/data/ datalinkage/nh3_file_layout_public_2010.pdf.
  15. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD- 10: preliminary estimates. Natl Vital Stat Rep 2001;49(2):1-32.
  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383.
  17. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47(11):1245-1251.
  18. Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61(12):1234- 1240.
  19. Korn EL, Graubard BI. Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 1991;81(9):1166-1173.
  20. Graubard BI, Korn EL. Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst 1999;91 (12):1005-1016.
  21. Davis DL, Hoel D, Fox J, Lopez A. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 1990;336 (8713):474-481.
  22. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 2004;110(5):522-527.
  23. Beaton GH, Corey PN, Steele C. Conceptual and methodological issues regarding the epidemiology of iron deficiency and their implications for studies of the functional consequences of iron deficiency. Am J Clin Nutr 1989;50(3 Suppl):575-585.
  24. Cook JD, Finch CA, Smith NJ. Evaluation of the iron status of a population. Blood 1976;48(3):449-455.
  25. Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27(7):681-687.
  26. Stevens RG, Cologne JB, Nakachi K, Grant EJ, Neriishi K. Body iron stores and breast cancer risk in female atomic bomb survivors. Cancer Sci 2011;102(12):2236-2240.
  27. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86(3):803-811.
  28. Klipstein-Grobusch K, Koster JF, Grobbee DE, Lindemans J, Boeing H, Hofman A, et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69(6):1231-1236.
  29. Cross AJ, Sinha R, Wood RJ, Xue X, Huang WY, Yeager M, et al. Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila) 2011;4(9):1465- 1475.
  30. Manttari M, Manninen V, Huttunen JK, Palosuo T, Ehnholm C, Heinonen OP, et al. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 1994;15(12):1599-1603.
  31. You SA, Wang Q. Ferritin in atherosclerosis. Clin Chim Acta 2005;357(1):1-16.
  32. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992;267(25):18148-18153.
  33. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992;12(5):417-427.

Cited by

  1. Iron Deficiency and Cardiovascular Disease: An Updated Review of the Evidence vol.15, pp.10, 2012, https://doi.org/10.1007/s11883-013-0358-0
  2. Non-Hfe Iron Overload: Is Phlebotomy the Answer? vol.12, pp.1, 2012, https://doi.org/10.1007/s11901-012-0153-3
  3. Iron: Protector or Risk Factor for Cardiovascular Disease? Still Controversial vol.5, pp.7, 2012, https://doi.org/10.3390/nu5072384
  4. Presence in the Pre-Surgical Fine-Needle Aspiration of Potential Thyroid Biomarkers Previously Identified in the Post-Surgical One vol.8, pp.9, 2012, https://doi.org/10.1371/journal.pone.0072911
  5. Transferrin saturation ratio: a method to estimate risk of cardiovascular mortality in the general population? vol.8, pp.7, 2012, https://doi.org/10.2217/bmm.14.70
  6. Dietary Iron Intake and Body Iron Stores Are Associated with Risk of Coronary Heart Disease in a Meta-Analysis of Prospective Cohort Studies vol.144, pp.3, 2012, https://doi.org/10.3945/jn.113.185124
  7. Prediabetes, elevated iron and all-cause mortality: a cohort study vol.4, pp.12, 2012, https://doi.org/10.1136/bmjopen-2014-006491
  8. Helicobacter pylori Seropositivity’s Association with Markers of Iron, 1-Carbon Metabolism, and Antioxidant Status among US Adults: A Structural Equations Modeling Approach vol.10, pp.3, 2015, https://doi.org/10.1371/journal.pone.0121390
  9. Parameters influencing in-hospital mortality in patients hospitalized in intensive cardiac care unit: is there an influence of anemia and iron deficiency? vol.10, pp.3, 2015, https://doi.org/10.1007/s11739-014-1170-8
  10. High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer vol.38, pp.3, 2012, https://doi.org/10.15537/smj.2017.3.16110
  11. Indices of iron homeostasis correlate with airway obstruction in an NHANES III cohort vol.12, pp.None, 2012, https://doi.org/10.2147/copd.s138457
  12. Targeting iron metabolism in drug discovery and delivery vol.16, pp.6, 2017, https://doi.org/10.1038/nrd.2016.248
  13. The association of ferritin with cardiovascular and all-cause mortality in community-dwellers: The English longitudinal study of ageing vol.12, pp.6, 2017, https://doi.org/10.1371/journal.pone.0178994
  14. Nano‐sensing and nano‐therapy targeting central players in iron homeostasis vol.13, pp.2, 2012, https://doi.org/10.1002/wnan.1667